Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

Robust base case NPV5% of $735 million (after-tax) and IRR of 41% at a $1,900 per ounce gold price assumption. Using a $2,500 gold price assumption, NPV5% is $1.2 billion (after-tax) and IRR is 58%.

India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion ...

Moreover, the decline in soil fertility under cotton, characterized by soil acidification, the emergence of new pests and ...

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the "Company", an emerging leader in age-reversal science, today announced significant findings from its co ...

PRNewswire/ - Franco-Nevada Corporation (" Franco-Nevada " or the " Company ") (TSX: FNV) (NYSE: FNV ) is pleased to announce ...

Detailed results are expected to be presented at a scientific forum in 2025 ... In the study, patients who met pre-specified inclusion criteria were randomized to receive one of two duvakitug doses or ...

If successfully developed and approved, DARE-LARC1 could provide women with unparalleled control over the management of their fertility to ... to provide effective contraception for an extended period ...

A public works company that falsely said it would retain a minority-owned subcontractor to win a contract urged an apparently divided U.S. Supreme Court on Monday to overturn the firm's mail fraud ...